title: Ofatumumab in a chronic lymphocytic leukemia patient with graft versus host disease and relapse after mini-allo BMT.
authors.affiliation: Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.
authors.forename: Laura
authors.initials: L
authors.lastname: Urian
authors.forename: Yves
authors.initials: Y
authors.lastname: Renaudineau
authors.forename: Christan
authors.initials: C
authors.lastname: Berthou
authors.forename: Mihnea
authors.initials: M
authors.lastname: Zdrenghea
authors.forename: Ljubomir
authors.initials: L
authors.lastname: Petrov
authors.forename: Adrian
authors.initials: A
authors.lastname: Tempescul
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D018951:Antigens, CD20; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D016026:Bone Marrow Transplantation / Q000009:adverse effects; D006086:Graft vs Host Disease / Q000209:etiology*; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D012008:Recurrence; D014184:Transplantation, Homologous
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D018951:Antigens, CD20; D000970:Antineoplastic Agents; C527517:ofatumumab